瘢痕化したの英語

手術後の瘢痕化抑制剤又は硝子体可視化剤として有用なトラニラスト含有製剤において、従来の経口連続投与に比べて、同等又はそれ以上の効果をゲル状懸濁剤または微細化懸濁液の提供。例文帳に追加

To provide a tranilast-containing preparation as a gel-like suspension preparation or micronized suspension useful as a scarring inhibitor or vitreous body visualizer after operation and having effects equivalent to or higher than the case with conventional continuous oral administration. - 特許庁

本発明は、式（１）に示す化合物の外用剤が皮膚組織障害の治療・予防・改善効果、特に皮膚のしみ、色素沈着、肝斑、雀卵斑、瘢痕等の皮膚組織の治療・予防・改善効果を見出した。例文帳に追加

It is discovered that the agent for external use, containing a compound represented by formula (I) has activities for treating, preventing and improving the dermal tissue disorder, especially stain, pigmentation, chloasma, fleckles, cicatrice, or the like, of the skin. - 特許庁

慢性閉塞性肺疾患の具体例としては、気管支（太い空気の通り道）に炎症と瘢痕化が起きる病態である慢性気管支炎と、肺胞（空気の入った微小な袋）が損傷を受けた病態である肺気腫が挙げられる。例文帳に追加

chronic obstructive pulmonary disease includes chronic bronchitis, in which the bronchi (large air passages) are inflamed and scarred, and emphysema, in which the alveoli (tiny air sacs) are damaged.発音を聞く  - PDQ®がん用語辞書 英語版

瘢痕形成の最小化が必須である整形外科などの外科手術、並びに内視鏡手術や顕微手術（ｍｉｃｒｏｓｕｒｇｅｒｙ）などスペースが限定された手術において特に有用な針と縫合糸の結合体の提供。例文帳に追加

To provide a combination of a needle and a suture which is especially useful in surgeries where minimization of scarring is imperative, such as orthopedic surgery, as well as in surgeries where space is limited, such as endoscopic surgery or microsurgery. - 特許庁

高い濃度で創傷治癒に改善創傷治癒を促進し、瘢痕形成も予防または軽減するマンノース−６−リン酸塩は、高濃度での効果は劣り、対照と比較してもさらに悪化するため、高い濃度で創傷治癒に効果のある組成を提案。例文帳に追加

To provide a composition having a wound healing effect at a high concentration to solve the conventional treatment using mannose-6-phosphate which promotes wound healing at high concentration and preventing or mitigating scar formation, but at a high concentration the effects depraves and depraves in comparing with comparison. - 特許庁

病的にコラーゲン線維等が蓄積することにより生じる疾患、例えば、肝硬変等の肝線維症、肺線維症、腎線維症、動脈硬化症、全身性硬化症、前立腺肥大症、ケロイド症、心筋症、膠原病及び瘢痕等の患者に対し、優れた線維化病変組織の修復剤又は線維化病変形成の阻止剤を提供する。例文帳に追加

To obtain an excellent repairing agent for fibrosing lesion tissue or an inhibitor against the formation of fibrosing lesion for a patient suffering from a disease caused by morbid accumulation of collagen fiber, or the like, e.g. hepatic fibrosis such as cirrhosis, pulmonary fibrosis, renal fibrosis, arteriosclerosis, systemic sclerosis, prostatic hypertrophy, keloidosis, cardiomyopathy, collagen disease and cicatrices. - 特許庁

下記式（ＩＩ） で表される骨格構造を有し且つ選択性の高いキマーゼ阻害活性を有する化合物、またはその薬理学上許容される塩を有効成分とする創傷治癒時の障害の治療剤または予防剤、特に癒着の治療剤または予防剤並びに瘢痕予防剤を提供する。例文帳に追加

A compound having a skeleton structure of formula (II) and highly selective chymase inhibiting activity or its pharmacologically permissible salt is used as an active component of the agent for the treatment or prevention of disorder in the healing of wound, especially an agent for the treatment or prevention of adhesion and an agent for preventing a cicatrix. - 特許庁

生体での創傷治癒過程を調節する際、損傷、外科手術、火傷などの物理的外傷や炎症に起因する癒着および／または瘢痕組織の形成を防止する際に用いる製品を製造するにあたっての、医薬活性を有する公知の化合物の使用を可能にする医薬製品を提供する。例文帳に追加

To provide a pharmaceutical product which enables the use of publicly known compounds having pharmaceutically activity in the manufacturing a product for use in the control of wound healing processes within the living body, in particular in the prevention of adhesion, and/or the formation of scar tissue, resulting from physical external injury including injury, surgery and burns, as well as from inflammation. - 特許庁